The ongoing company can solicit rival offers through Feb. 19, within the deal.. Immunomedics in $2 bln licensing deal with Seattle Genetics – Drug creator Immunomedics Inc stated on Fri it entered right into a advancement and licensing offer well worth up to $2 billion because of its experimental cancer medication with Seattle Genetics Inc.72 in morning hours trading. Stocks of Seattle Genetics, which forecast full-year income below quotes on Thursday night, were straight down 4.2 % at $60.17. Immunomedics, in Oct engaged Greenhill & Co to aid in licensing out the medication which, IMMU-132, can receive $250 million in upfront money payment.Employees clean the roofing of Country wide Grand Theatre on the polluted day time in Beijing, China, 15 february, 2017. REUTERS/Jason LeeNew proof and methodologies imply that the estimation is significantly greater than the shape published with the Globe Health Organization this past year, which place the real quantity of global surroundings pollution-related fatalities in 2012 at 3 million, HEI said. The institute, which includes also launched an internet data source showing the global impact of pollution on wellness ( said 92 % from the world’s human population lives in areas with harmful air.